Oneness Biotech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 1,016.84 million compared to TWD 12.73 million a year ago. Net income was TWD 338.49 million compared to net loss of TWD 472.73 million a year ago. Basic earnings per share from continuing operations was TWD 0.7647 compared to basic loss per share from continuing operations of TWD 1.0899 a year ago. Diluted earnings per share from continuing operations was TWD 0.7647 compared to diluted loss per share from continuing operations of TWD 1.0899 a year ago.
For the six months, sales was TWD 1,036.93 million compared to TWD 23.71 million a year ago. Net income was TWD 727.03 million compared to net loss of TWD 355.54 million a year ago. Basic earnings per share from continuing operations was TWD 1.6524 compared to basic loss per share from continuing operations of TWD 0.8262 a year ago. Diluted earnings per share from continuing operations was TWD 1.6348 compared to diluted loss per share from continuing operations of TWD 0.8262 a year ago.